Twist Bioscience Corp CEO Emily M. Leproust sells $619,193 of TWST
An open-market sale on Nov 3, reported to the SEC on Nov 5, not marked as part of a 10b5-1 plan. Information only, not investment advice.
Twist Bioscience Corp's chief executive officer, Emily M. Leproust, sold 4,573 shares of the company's stock on the open market on Nov 3. The sale, at an average of $135.40 a share, comes to $619,193.
The filing does not mark the sale as made under a Rule 10b5-1 trading plan. After the trade, the filing lists 558,187 shares held.
Five Twist Bioscience Corp insiders sold on the open market within 14 days, a pattern known as a cluster sell. The trade was reported within two business days, as Section 16 requires.
The numbers below are taken from the Form 4 as filed with the SEC.
| Company | Twist Bioscience Corp (TWST) |
|---|---|
| Insider | Emily M. Leproust |
| Role | CEO |
| Transaction | Open-market sale (code S) |
| Shares | 4,573 |
| Average price | $135.40 |
| Value | $619,193 |
| Trade date | Nov 3, 2026 |
| Filed with the SEC | Nov 5, 2026, 4:05 PM ET |
| Shares held after | 558,187 |
| Ownership | Direct |
| Rule 10b5-1 plan | Not marked in the filing |
Open the full breakdown of this TWST trade
See where several insiders traded together · Browse the insider trading newsroom
Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.
Related Articles
- Insider Trading News
Five insiders sell Twist Bioscience Corp shares, $1.55M in total
- Insider Trading News
Twist Bioscience Corp president Patrick John Finn sells $347,306 in shares
- Insider Trading News
Twist Bioscience Corp SVP of human resources Paula Green trims stake with $136,350 sale
- Insider Trading News
Twist Bioscience Corp officer Dennis Cho sells 949 shares worth $128,497
- Stock Markets News
Why is Twist Bioscience stock sliding today?